(c) 2024 PillSync.com

Labetalol 200 mg

INDICATIONS & USAGE Labetalol hydrochloride tablets, USP are indicated in the management of hypertension. Labetalol hydrochloride tablets, USP may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics.

par pharmaceutical, inc.


3 years ago ROUND WHITE N T 042 Labetalol 200 mg

ROUND WHITE N T 042

3 years ago ROUND WHITE N T 042 Labetalol 200 mg

N T 042 ROUND WHITE

HOW SUPPLIED

LABETALOL HYDROCHLORIDE tablets, USP 100 mg, white, round, film-coated tablets with bisect, debossed “N†on top and “T†on bottom of the bisect on one side and "041" on the other side of the tablet, bottles of 100 (NDC 49884-122-01) and 500 (NDC 49884-122-05).

LABETALOL HYDROCHLORIDE tablets, USP 200 mg, white, round, film-coated tablets with bisect, debossed “N†on top and “T†on bottom of the bisect on one side and "042" on the other side of the tablet, bottles of 100 (NDC 49884-123-01) and 500 (NDC 49884-123-05).

LABETALOL HYDROCHLORIDE tablets, USP 300 mg, white, round, film-coated tablets with bisect, debossed “N†on top and “T†on bottom of the bisect on one side and "043" on the other side of the tablet, bottles of 100 (NDC 49884-124-01) and 500 (NDC 49884-124-05).

LABETALOL HYDROCHLORIDE tablets, USP should be stored at 20° to 25°C (68° to 77°F)[ See USP Controlled Room Temperature]. Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Formulations Private Limited, 9/215, Pudupakkam, Kelambakkam - 603 103. Made in India. Mfg. Lic. No.: TN00002121 OS122-01-74-01 Revised: 03/2017


More pills like ROUND N T 042

Related Pills

Labetalol 200 mg

par pharmaceutical, inc.

Labetalol 100 mg

par pharmaceutical, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site